Investigative Toxicology and Discovery Toxicology Team Leader at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • PhD in Toxicology or 7+ years of experience in the toxicology field
  • Mechanistic toxicology lab experience
  • Discovery and Development Toxicology Project Leader experience
  • Strong communication skills with the ability to engage with key partners
  • Additional Skills/Preferences
  • Proven track record of leading and managing research teams
  • Extensive knowledge of toxicological principles, methodologies, and regulatory requirements
  • Experience in the drug discovery and development process
  • Strong analytical and problem-solving skills
  • Excellent communication and presentation abilities
  • Ability to work collaboratively in a multidisciplinary environment

Responsibilities

  • Lead and manage a team of scientists responsible for interrogating mechanisms of action and driving technical innovations
  • Lead a team of Toxicology Project Leaders responsible for delivering candidate ready molecules into development
  • Analyze and interpret complex data, providing clear and concise reporting and recommendations
  • Collaborate with cross-functional teams to ensure comprehensive evaluation of toxicological risks
  • Present findings to partners
  • Stay updated with the latest advancements in toxicology and integrate new methodologies into research practices
  • Mentor and develop team members, fostering a culture of continuous learning and professional growth

Skills

Mechanistic Toxicology
Discovery Toxicology
Toxicology Project Leadership
Data Analysis
Scientific Communication
Team Leadership
Cross-functional Collaboration
Mentoring
Toxicological Risk Assessment

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI